News
Eurocine Vaccines presentation på Småbolagsdagarna i Stockholm
Eurocine Vaccines presenterade bolaget, utvecklingen av ett klamydiavaccin och den mycket intressanta nytillkomna vaccinkandidaten mot Herpes simplexvirus typ 2 på Småbolagsdagarna i Stockholm den 15…
Eurocine Vaccines presenterar på Småbolagsdagarna i Stockholm idag onsdag den 15 juni 2022
Eurocine Vaccines kommer att presentera bolaget, utvecklingen av ett klamydiavaccin och den mycket intressanta nytillkomna vaccinkandidaten mot Herpes simplexvirus typ 2 på Småbolagsdagarna i Stockholm,…
Eurocine Vaccines expands its portfolio with a therapeutic HSV-2 vaccine candidate
Eurocine Vaccines AB ("Eurocine Vaccines") hereby announces that the company has entered into a research and collaboration agreement with Redbiotec AG ("Redbiotec"). The agreement gives…
Calendar
BIO-Europe
BIO-Europe has grown into Europe’s largest partnering conference serving the global biotechnology industry. Delegates from all parts of the biotechnology value chain have come togetherRead…
Biotechgate Digital Partnering
Eurocine Vaccines, a dedicated and returning participant, will join the Biotechgate Digital Partnering to meet with people in the vaccine area, both new connections and already establishedRead…